Regulacje i polityka gospodarcza · 13/09/2022

NIH Requests OMB Review for Human Embryonic Stem Cell Line Approval

The National Institutes of Health (NIH) Office of the Director has submitted a 30-day comment request to the Office of Management and Budget (OMB) for approval of a human embryonic stem cell line for use in NIH-funded research, in compliance with the Paperwork Reduction Act of 1995.